Search results
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 4 days agoUntil now the biosimilars have gained minimal traction. The number of new prescriptions written for...
Q1 2024 CVS Health Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoAndrew Kane; Executive VP & President of Aetna; CVS Health Corporation J. David Joyner; EVP & President of CVS Caremark; CVS Health Corporation Karen Sue ...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill via AOL· 3 days agoDrug manufacturing giant GSK is subverting its pledge to lower the price of its brand-name inhaler...
CVS Health Corp (CVS) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
GuruFocus.com via Yahoo Finance· 4 days ago(NYSE:CVS) implemented significant formulary changes related to Humira, successfully dispensing more biosimilar Humira prescriptions in the first month than the entire U.S. market in 2023, highlighting ...
Policymakers should support patients over profits in Louisiana
Louisiana Illuminator via Yahoo News· 7 days agoEvery year, more than 26,000 Louisianans are diagnosed with cancer. Our state has the sixth-highest...
SREE CHAGUTURU, MD, CHIEF MEDICAL OFFICER, CVS HEALTH, BECOMES CHAIR OF THE AMERICAN TELEMEDICINE...
FOX 59 Indianapolis· 3 days agoThe American Telemedicine Association (ATA) today announced that Sree Chaguturu, MD, has become...
Aetna hit with $900M in surprise MA costs, CVS Health reports
Modern Healthcare· 5 days agoAetna is eyeing benefit cuts and other measures to lift Medicare Advantage profit margins from -3% to at least 4% over the next few years, CVS Health executives said.
Draft rule requiring pharmacy payments hits roadblock - Talk Business & Politics
Talk Business & Politics· 3 days agoA draft Arkansas Insurance Department rule that would have required pharmacy benefit managers to...
CVS posts big earnings miss, cuts profit outlook on higher medical costs
CNBC· 5 days agoCVS Health on Wednesday reported first-quarter revenue and adjusted earnings that missed expectations and slashed its full-year profit outlook, citing higher medical costs that are dogging the ...
Mendez: Price caps on inhalers won’t do enough
Boston Herald· 2 days agoPresident Biden recently held an event to celebrate that three major drugmakers announced they are putting a $35 monthly out-of-pocket price cap on...